Edition:
United States

Mallinckrodt Plc (MNK.N)

MNK.N on New York Stock Exchange

19.44USD
4:00pm EDT
Change (% chg)

$-0.75 (-3.71%)
Prev Close
$20.19
Open
$20.01
Day's High
$20.07
Day's Low
$19.32
Volume
510,280
Avg. Vol
783,085
52-wk High
$49.08
52-wk Low
$11.66

Chart for

About

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and... (more)

Overall

Beta: 1.26
Market Cap(Mil.): $1,676.65
Shares Outstanding(Mil.): 83.08
Dividend: --
Yield (%): --

Financials

  MNK.N Industry Sector
P/E (TTM): 1.51 29.56 34.04
EPS (TTM): 13.34 -- --
ROI: 8.82 13.58 13.11
ROE: 21.47 15.39 15.11

BRIEF-Mallinckrodt Reports Q1 Adjusted Earnings Per Share Of $1.31

* Q1 ADJUSTED LOSS PER SHARE $0.50 FROM CONTINUING OPERATIONS

May 08 2018

BRIEF-Mallinckrodt Reports On FDA Joint Advisory Committee Meeting For Stannsoporfin

* MALLINCKRODT REPORTS ON FDA JOINT ADVISORY COMMITTEE MEETING FOR STANNSOPORFIN FOR THE TREATMENT OF NEWBORNS AT RISK OF DEVELOPING SEVERE JAUNDICE

May 03 2018

BRIEF-Mallinckrodt Announces $300 Million Debt Repayment

* MALLINCKRODT PLC - COMPANY REPAYS DEBT MATURING APRIL 2018 WITH CASH ON HAND

Apr 16 2018

BRIEF-Mallinckrodt Names Paul Carter, Anne Whitaker To Its Board Of Directors

* MALLINCKRODT NAMES PAUL R. CARTER, ANNE C. WHITAKER TO ITS BOARD OF DIRECTORS

Apr 04 2018

BRIEF-Angus Russell To Succeed Melvin Booth As Mallinckrodt Board Chairman In May 2018

* ANGUS RUSSELL TO SUCCEED MELVIN BOOTH AS MALLINCKRODT CHAIRMAN OF THE BOARD IN MAY 2018

Apr 04 2018

BRIEF-Evoke Announces Agreement With Mallinckrodt To Amend Milestone Payments

* EVOKE ANNOUNCES AGREEMENT WITH MALLINCKRODT TO AMEND MILESTONE PAYMENTS

Mar 26 2018

Judge rejects Mallinckrodt lead plaintiff challenge

A federal judge has approved an Ohio state pension system to serve as the lead plaintiff in a shareholder class action lawsuit against Mallinckrodt PLC, rejecting arguments that it should be disqualified due to political contributions by two law firms representing it.

Mar 12 2018

U.S. subpoenas Mallinckrodt for information on opioid painkillers

Pharmaceutical company Mallinckrodt Plc said on Tuesday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to generic drugs it produces that contain the opioid painkiller oxymorphone.

Feb 27 2018

UPDATE 1-U.S. subpoenas Mallinckrodt for information on opioid painkillers

Feb 27 Pharmaceutical company Mallinckrodt Plc said on Tuesday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to generic drugs it produces that contain the opioid painkiller oxymorphone.

Feb 27 2018

U.S. subpoenas Mallinckrodt for information on opioid painkillers

Feb 27 Pharmaceutical company Mallinckrodt Plc on Tuesday said that it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to generic drugs it produces that contain the opioid painkiller oxymorphone.

Feb 27 2018

Competitors

  Price Chg
Meda AB (MEDAa.ST) -- --
Merck KGaA (MRCG.DE) €82.84 +0.10
AB Science SA (ABS.PA) €4.73 --

Earnings vs. Estimates